Page 366 - Billion News Today

(Oslo, 2 June 2023) Today, Statkraft has issued a EUR 500 million senior bond under its EMTN (Euro Medium Term Note) programme. The bond matures in June 2033 and pays a fixed coupon of 3.500%. The transaction

Caffyns PLC - Eastbourne, Sussex-based car dealership - Revenue for the year ended March 31 rises 12% to GBP251.4 million from GBP223.9 million. Pretax profit falls to GBP3.1 million from GBP4.4... | June 2, 2023

Cascadia Blockchain Group Corp. reported earnings results for the full year ended January 31, 2023. For the full year, the company reported net loss was CAD 0.944255 million compared to CAD 0.056304... | June 2, 2023

DUBLIN - BD , a leading global medical technology company, today held a grand opening ceremony for a new €4 million research and development facility in Blackrock, Dublin and announced... | June 2, 2023

Rising UGV procurement contracts and the creation of autonomous robots for a variety of uses PUNE, India, June 2, 2023 /PRNewswire/ -- Exactitude Consultancy, the market research and consulting

Cap-XX Ltd - Sydney-based supercapacitor and energy management system manufacturer - Applies to admit 129.2 million new shares to be admitted to trading on AIM after shareholders vote in favour of... | June 2, 2023

Deportation flight from Valley sends migrants to Colombia 6 Fernando Del Valle, Valley Morning Star, Harlingen, Texas Thu, June 1, 2023 at 11:48 PM

By Dominic Chopping Norways Kongsberg Gruppen said Friday it has received an order worth 1.35 billion Norwegian kroner from Raytheon for naval strike missiles to the U.S. Navy. Raytheon... | June 2, 2023

Marks & Spencers PLC - London-based food, clothing, home and bank services retailer - Says it has tendered GBP107.2 million of GBP300.0 million 3.750% notes that are due in 2026, and that it has... | June 2, 2023

Acute-on-chronic liver failure (ACLF) occurs in 30% of hospitalized cirrhosis patients, leading to over one million deaths worldwide each year. Currently, the only potential treatment for this condition is liver transplantation, which is available to very few patients. A first-in-human randomized controlled clinical trial using DIALIVE, a novel liver dialysis device, demonstrated its potential as a disease-modifying therapy and resolved liver failure significantly faster and in a greater p...